OTC Markets EXMKT - Delayed Quote USD

Lucy Scientific Discovery Inc. (LSDIF)

0.0002
0.0000
(0.00%)
At close: May 27 at 4:00:00 PM EDT
Loading Chart for LSDIF
  • Previous Close 0.0002
  • Open 0.0002
  • Bid --
  • Ask --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0001 - 0.9300
  • Volume 562
  • Avg. Volume 866
  • Market Cap (intraday) 353
  • Beta (5Y Monthly) -38.42
  • PE Ratio (TTM) --
  • EPS (TTM) -7.6400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Lucy Scientific Discovery Inc., an early stage psychotropics contract manufacturing company, engaged in the research, manufacturing, and commercialization of psychedelic products. The company offers biological raw materials, active pharmaceutical ingredients (APIs), and finished biopharmaceutical products. It also develops and produces highly controlled agricultural grow environments for plant manufacturing and replication applications. The company was formerly known as Hollyweed North Cannabis Inc. and changed its name to Lucy Scientific Discovery Inc. in May 2021. Lucy Scientific Discovery Inc. was incorporated in 2017 and is headquartered in Victoria, Canada.

www.lucyscientific.com

2

Full Time Employees

June 30

Fiscal Year Ends

Recent News: LSDIF

Más detalles

Performance Overview: LSDIF

Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LSDIF
96.00%
S&P 500 (^GSPC)
0.51%

1-Year Return

LSDIF
99.98%
S&P 500 (^GSPC)
12.92%

3-Year Return

LSDIF
100.00%
S&P 500 (^GSPC)
42.17%

5-Year Return

LSDIF
100.00%
S&P 500 (^GSPC)
94.19%

Comparar con: LSDIF

Puedes seleccionar hasta 4 acciones para analizar empresas similares utilizando métricas clave de rendimiento.

Statistics: LSDIF

Más detalles

Valuation Measures

Annual
As of 5/30/2025
  • Market Cap

    352.00

  • Enterprise Value

    2.00M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.02

  • Price/Book (mrq)

    0.00

  • Enterprise Value/Revenue

    119.68

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -99.35%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    16.73k

  • Net Income Avi to Common (ttm)

    -10.23M

  • Diluted EPS (ttm)

    -7.6400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    211.12k

  • Total Debt/Equity (mrq)

    85.69%

  • Levered Free Cash Flow (ttm)

    -6.54M

Research Analysis: LSDIF

Más detalles

Company Insights: LSDIF

Reportes de investigación: LSDIF

Más detalles